Although some differences in measured BC activity were also observed according to different tumor histotypes, hormonal receptors expression (estrogen receptor (ER) and progesterone receptor (PR)) and grading, the tumor histological characteristics seem not or only partially accountable for the variations in primary BC activity. Here, NR4A1 is linked to breast cancer.